SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug tested for most dangerous seizures
Disease control CompletedThis study tested an experimental drug called SAGE-547 in patients with super-refractory status epilepticus, a severe and life-threatening condition where seizures do not stop despite multiple medications. The main goal was to see if the drug was safe and could help control these…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 04, 2026 07:49 UTC
-
Experimental drug tested for most dangerous form of epileptic seizures
Disease control CompletedThis Phase 3 trial tested whether SAGE-547 injection could help patients with super-refractory status epilepticus—a life-threatening condition where seizures continue despite multiple medications. The study involved 132 patients aged 2 and older who had failed standard treatments…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC